Influence of Concomitant Administrations on the Clearance of Theophylline as Analyzed by Population Pharmacokinetics
暂无分享,去创建一个
[1] D. Adam,et al. Macrolide Antibacterials , 1995, Drug safety.
[2] A. Freiburghaus,et al. Metabolism of theophylline by cDNA-expressed human cytochromes P-450. , 1995, British journal of clinical pharmacology.
[3] E. Yukawa,et al. Phenobarbitone Population Pharmacokinetics from Routine Clinical Data: Role of Patient Characteristics for Estimating Dosing Regimens , 1992, The Journal of pharmacy and pharmacology.
[4] E. Yukawa,et al. Digoxin Population Pharmacokinetics from Routine Clinical Data: Role of Patient Characteristics for Estimating Dosing Regimens , 1992, The Journal of pharmacy and pharmacology.
[5] P. Watkins. Drug metabolism by cytochromes P450 in the liver and small bowel. , 1992, Gastroenterology clinics of North America.
[6] E. Mini,et al. Pharmacokinetic Drug Interactions of Macrolides , 1992, Clinical pharmacokinetics.
[7] J. Brouwers. Drug Interactions with Quinolone Antibacterials , 1992, Drug safety.
[8] L B Sheiner,et al. Premarketing observational studies of population pharmacokinetics of new drugs , 1985, Clinical pharmacology and therapeutics.
[9] R. Manfredi,et al. Inhibition of theophylline metabolism by long‐term allopurinol administration , 1981, Clinical pharmacology and therapeutics.
[10] J J Schentag,et al. Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol. , 1979, Journal of pharmaceutical sciences.
[11] R. Ogilvie. Clinical Pharmacokinetics of Theophylline , 1978, Clinical pharmacokinetics.
[12] W. Jusko,et al. Effect of smoking on theophylline disposition , 1976, Clinical pharmacology and therapeutics.